Varian to Acquire Software Platform for Data-Driven Clinical Decision Making in Cancer Centers
By MedImaging International staff writers Posted on 17 Mar 2014 |
Varian Medical Systems, Inc., (Palo Alto, CA, USA) has signed an agreement with Velocity Medical Solutions, LLC (Atlanta, GA, USA) to acquire specific assets of Velocity, a privately-held developer of specialized software for cancer clinics.
The acquisition includes software designed to access and aggregate unstructured treatment and imaging data from diverse systems to show a wide-ranging view of a patient’s diagnostic imaging and treatment history, regardless of where they were treated or what technology was used. By organizing patient data and making it available in one place, the Velocity software can help clinicians make more informed treatment decisions.
The Velocity organization was established by leading clinicians who have developed novel tools that convert unstructured data into useful clinical knowledge. The Velocity software enables clinicians to easily gather, integrate, and share data from computed tomography (CT), positron emission tomography (PET), and magnetic resonance (MR) images and varied treatment systems for close collaboration with referring oncologists, physicians, medical physicists, and others on the care team.
The Velocity software is already in use at over 200 cancer treatment centers worldwide. Varian anticipates its global sales, service, and support network will contribute to faster and deeper market penetration for the Velocity product.
“This acquisition supports our commitment to providing clinicians with tools for data-driven clinical decision making,” said Kolleen Kennedy, president of Varian’s oncology systems business. “We believe that the Velocity software has the potential to play an important role at the over 4,400 cancer centers currently utilizing Varian technology. The software enables healthcare professionals to use oncology patient images and data to plan and assess treatments, collaborate with colleagues, and share clinical knowledge—all important capabilities in an era of evidence-based medicine.”
The Velocity solution is in line with Varian’s overall goal of helping clinicians manage the cancer treatment journey, from initial diagnosis to survivorship, and including retreatment for the some 30% of patients who will experience metastases at some time.
“Varian strives to provide oncologists with curative tools for their patients. When a cure is not possible, our vision is to turn cancer into a manageable disease like diabetes,” said Kennedy. “With approaches like image-guided radiosurgery, a patient might be successfully treated multiple times for their primary cancer and then for metastatic lesions that can occur, sometimes months or even years later. We envision clinicians using this software to fully understand a patient’s clinical history in order to make informed decisions about the path forward.”
“We are excited about the possibilities that this acquisition by Varian creates,” said Tim Fox, PhD, director of medical physics for the department of radiation oncology at Emory University (Atlanta, GA, USA) and one of the founders of Velocity Medical Solutions. “We expect that Varian will support the continued development of this important clinical tool and help to make it more widely available. We share a common vision to empower oncology care teams to make more confident decisions.”
Varian plans to continue development of this oncology software platform with the Velocity team in Atlanta, Georgia. Financial terms of the asset acquisition are not being disclosed. The acquisition is expected to be complete during Varian’s third fiscal quarter, subject to customary closing conditions.
Varian Medical Systems is a developer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers, and medical oncology practices. Varian is a supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection.
Related Links:
Varian Medical Systems
Velocity Medical Solutions
The acquisition includes software designed to access and aggregate unstructured treatment and imaging data from diverse systems to show a wide-ranging view of a patient’s diagnostic imaging and treatment history, regardless of where they were treated or what technology was used. By organizing patient data and making it available in one place, the Velocity software can help clinicians make more informed treatment decisions.
The Velocity organization was established by leading clinicians who have developed novel tools that convert unstructured data into useful clinical knowledge. The Velocity software enables clinicians to easily gather, integrate, and share data from computed tomography (CT), positron emission tomography (PET), and magnetic resonance (MR) images and varied treatment systems for close collaboration with referring oncologists, physicians, medical physicists, and others on the care team.
The Velocity software is already in use at over 200 cancer treatment centers worldwide. Varian anticipates its global sales, service, and support network will contribute to faster and deeper market penetration for the Velocity product.
“This acquisition supports our commitment to providing clinicians with tools for data-driven clinical decision making,” said Kolleen Kennedy, president of Varian’s oncology systems business. “We believe that the Velocity software has the potential to play an important role at the over 4,400 cancer centers currently utilizing Varian technology. The software enables healthcare professionals to use oncology patient images and data to plan and assess treatments, collaborate with colleagues, and share clinical knowledge—all important capabilities in an era of evidence-based medicine.”
The Velocity solution is in line with Varian’s overall goal of helping clinicians manage the cancer treatment journey, from initial diagnosis to survivorship, and including retreatment for the some 30% of patients who will experience metastases at some time.
“Varian strives to provide oncologists with curative tools for their patients. When a cure is not possible, our vision is to turn cancer into a manageable disease like diabetes,” said Kennedy. “With approaches like image-guided radiosurgery, a patient might be successfully treated multiple times for their primary cancer and then for metastatic lesions that can occur, sometimes months or even years later. We envision clinicians using this software to fully understand a patient’s clinical history in order to make informed decisions about the path forward.”
“We are excited about the possibilities that this acquisition by Varian creates,” said Tim Fox, PhD, director of medical physics for the department of radiation oncology at Emory University (Atlanta, GA, USA) and one of the founders of Velocity Medical Solutions. “We expect that Varian will support the continued development of this important clinical tool and help to make it more widely available. We share a common vision to empower oncology care teams to make more confident decisions.”
Varian plans to continue development of this oncology software platform with the Velocity team in Atlanta, Georgia. Financial terms of the asset acquisition are not being disclosed. The acquisition is expected to be complete during Varian’s third fiscal quarter, subject to customary closing conditions.
Varian Medical Systems is a developer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers, and medical oncology practices. Varian is a supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection.
Related Links:
Varian Medical Systems
Velocity Medical Solutions
Latest Industry News News
- GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
- Patient-Specific 3D-Printed Phantoms Transform CT Imaging
- Siemens and Sectra Collaborate on Enhancing Radiology Workflows
- Bracco Diagnostics and ColoWatch Partner to Expand Availability CRC Screening Tests Using Virtual Colonoscopy
- Mindray Partners with TeleRay to Streamline Ultrasound Delivery
- Philips and Medtronic Partner on Stroke Care
- Siemens and Medtronic Enter into Global Partnership for Advancing Spine Care Imaging Technologies
- RSNA 2024 Technical Exhibits to Showcase Latest Advances in Radiology
- Bracco Collaborates with Arrayus on Microbubble-Assisted Focused Ultrasound Therapy for Pancreatic Cancer
- Innovative Collaboration to Enhance Ischemic Stroke Detection and Elevate Standards in Diagnostic Imaging
- RSNA 2024 Registration Opens
- Microsoft collaborates with Leading Academic Medical Systems to Advance AI in Medical Imaging
- GE HealthCare Acquires Intelligent Ultrasound Group’s Clinical Artificial Intelligence Business
- Bayer and Rad AI Collaborate on Expanding Use of Cutting Edge AI Radiology Operational Solutions
- Polish Med-Tech Company BrainScan to Expand Extensively into Foreign Markets
- Hologic Acquires UK-Based Breast Surgical Guidance Company Endomagnetics Ltd.
Channels
Radiography
view channel
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read more
AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
Percutaneous coronary intervention (PCI), also known as coronary angioplasty, is a minimally invasive procedure where small metal tubes called stents are inserted into partially blocked coronary arteries... Read moreMRI
view channel
AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more
Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
Approximately 360,000 individuals in the UK suffer from focal epilepsy, a condition in which seizures spread from one part of the brain. Around a third of these patients experience persistent seizures... Read more
AI-Powered MRI Technology Improves Parkinson’s Diagnoses
Current research shows that the accuracy of diagnosing Parkinson’s disease typically ranges from 55% to 78% within the first five years of assessment. This is partly due to the similarities shared by Parkinson’s... Read more
Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
Artificial intelligence (AI) technologies are transforming the way medical images are analyzed, offering unprecedented capabilities in quantitatively extracting features that go beyond traditional visual... Read moreUltrasound
view channel.jpeg)
AI-Powered Lung Ultrasound Outperforms Human Experts in Tuberculosis Diagnosis
Despite global declines in tuberculosis (TB) rates in previous years, the incidence of TB rose by 4.6% from 2020 to 2023. Early screening and rapid diagnosis are essential elements of the World Health... Read more
AI Identifies Heart Valve Disease from Common Imaging Test
Tricuspid regurgitation is a condition where the heart's tricuspid valve does not close completely during contraction, leading to backward blood flow, which can result in heart failure. A new artificial... Read moreNuclear Medicine
view channel
Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
COX-2, an enzyme that plays a key role in brain inflammation, can be significantly upregulated by inflammatory stimuli and neuroexcitation. Researchers suggest that COX-2 density in the brain could serve... Read more
Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC), which represents 15-20% of all breast cancer cases, is one of the most aggressive subtypes, with a five-year survival rate of about 40%. Due to its significant heterogeneity... Read moreGeneral/Advanced Imaging
view channel
AI-Powered Imaging System Improves Lung Cancer Diagnosis
Given the need to detect lung cancer at earlier stages, there is an increasing need for a definitive diagnostic pathway for patients with suspicious pulmonary nodules. However, obtaining tissue samples... Read more
AI Model Significantly Enhances Low-Dose CT Capabilities
Lung cancer remains one of the most challenging diseases, making early diagnosis vital for effective treatment. Fortunately, advancements in artificial intelligence (AI) are revolutionizing lung cancer... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more